Current status of haemophilia inhibitor management in mainland China: a haemophilia treatment centres survey on treatment preferences and real‐world clinical practices-Reference-Cited by-同舟云学术

Current status of haemophilia inhibitor management in mainland China: a haemophilia treatment centres survey on treatment preferences and real‐world clinical practices

Published:2021-08 Issue:4 Volume:194 Page:750-758
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br. J. Haematol.

Author:

Liu Wei¹^ORCID,Xue Feng¹^ORCID,Poon Man‐Chiu²³^ORCID,Chen Lingling¹,Jin Zhaona¹,Zhang Lei¹,Yang Renchi¹

Affiliation:

1. State Key Laboratory of Experimental Hematology National Clinical Research Center for Blood Diseases Institute of Hematology and Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College Tianjin Laboratory of Blood Disease Gene Therapy CAMS Key Laboratory of Gene Therapy for Blood Diseases CAMS Center for Stem Cell Medicine PUMC Department of Stem Cell and Regenerative Medicine Tianjin China

2. Departments of Medicine, Pediatrics and Oncology University of Calgary Cumming School of Medicine CalgaryCanada

3. Southern Alberta Rare Blood and Bleeding Disorders Comprehensive Care Program Foothills Medical Centre Alberta Health Services Calgary Canada

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17677

Reference20 articles.

1. Healthcare resource utilization among haemophilia A patients in the United States

2. Haemophilia care in China: Achievements in the past decade

3. Inhibitors in Hemophilia: Treatment Challenges and Novel Options

4. Chinese guidelines on the treatment of hemophilia (Version 2020);Thrombosis and Hemostasis Group, Chinese Society of Hematology, Chinese Medical Association/Hemophilia Treatment Center Collaborative Network of China;Zhonghua Xue Ye Xue Za Zhi,2020

5. Patients with haemophilia A with inhibitors in China: a national real‐world analysis and follow‐up

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Report on the diagnosis and treatment of hemophilia in China (Version 2024);LabMed Discovery;2024-07

2. The Role of Clot Waveform Analysis and Related Parameters in the Diagnosis and Treatment of Hemophilia A;Thrombosis and Haemostasis;2024-04-16

3. The importance and evolution of bleeding disorder registries;Haemophilia;2024-04

4. Hemophilia a patients with inhibitors: Mechanistic insights and novel therapeutic implications;Frontiers in Immunology;2022-12-08

5. Inhibitors: Diagnostic challenges, unknowns of inhibitor development, treatment of bleeding and surgery, and insights into diagnosis and treatment in China;Haemophilia;2022-05